Oregon Administrative Rules › Chapter 333 - OREGON HEALTH AUTHORITY, PUBLIC HEALTH DIVISION › Division 18 - DISEASE REPORTING › Section 333-018-0018 - Submission of Organisms or Specimens to the Public Health Laboratory

Current through Register Vol. 63, No. 7, July 1, 2024
Licensed laboratories are required to forward aliquots,
				specimens or cultures of the following organisms to the Oregon State Public
				Health Laboratory:
(1) Select
			 biological agents and toxins: Avian influenza virus; Bacillus anthracis;
			 Botulinum neurotoxins; Botulinum neurotoxin producing species of Clostridium;
			 Brucella abortus; Brucella melitensis; Brucella suis; Burkholderia mallei;
			 Burkholderia pseudomallei; Conotoxin; Coxiella burnetii; Crimean-Congo
			 hemorrhagic fever virus; Diacetoxyscirpenol; Eastern Equine Encephalitis virus;
			 Ebola virus; Francisella tularensis; Hendra virus; Lassa fever virus; Lujo
			 virus; Marburg virus; Monkeypox virus; Newcastle disease virus; Nipah virus;
			 Reconstructed replication competent forms of the 1918 pandemic influenza virus
			 containing any portion of the coding regions of all eight gene segments
			 (Reconstructed 1918 Influenza virus); Ricin; Rickettsia prowazekii; Rift Valley
			 fever virus; SARS-associated coronavirus (SARS-CoV), Saxitoxin; Sheep pox
			 virus; South American Hemorrhagic Fever viruses (Chapare, Guanarito, Junin,
			 Machupo, Sabia); Staphylococcal enterotoxins A,B,C,D,E subtypes; T-2 toxin,
			 Tetrodotoxin; Tick-borne encephalitis complex (flavi) viruses (Far Eastern
			 subtype; Siberian subtype); Kyasanur Forest disease virus; Omsk hemorrhagic
			 fever virus; Variola major virus (Smallpox virus); Variola minor virus
			 (Alastrim); Venezuelan equine encephalitis virus; and Yersinia
			 pestis.
(2) Other organisms or
			 specimens including:
(a) From persons of any
			 age:
(A) All isolates of Corynebacterium
			 diphtheriae, Grimontia spp., Listeria spp., Mycobacterium tuberculosis and M.
			 bovis, Salmonella spp., Shigella spp., Vibrio spp., and Yersinia spp. and
			 suspected Shiga-toxigenic Escherichia coli (STEC), including E. coli
			 O157;
(B) All isolates of
			 Acinetobacter species and Enterobacterales order bacteria resistant to any
			 carbapenem antibiotic;
(C) All
			 isolates of any organism known to be carbapenemase-producing;
(D) All isolates of suspected Neisseria
			 meningitidis and Haemophilus influenzae from normally sterile sites;
(E) All specimens that test positive by
			 antigen-detection or nucleic acid testing for Listeria, Salmonella, Shigella,
			 Vibrio, or Yersinia, for which culture has not been attempted;
(F) All specimens that test positive by
			 antigen-detection or nucleic acid testing for Shiga toxin, and from which
			 Escherichia coli O157 has not been isolated.
(G) All specimens that test positive for
			 Measles (rubeola), poliomyelitis, rabies (human), rubella, yellow fever, and
			 all novel and highly pathogenic avian influenza strains;
(H) All specimens from normally sterile sites
			 testing positive for Haemophilus influenzae or Neisseria meningitidis by
			 non-culture methods; and
(I) All
			 isolates of Candida auris, Coccidioides spp., and Cryptococcus spp.